Lecture on Viral Replication and Pathogenesis
Multiplication Cycle of Viruses
Misnomer of Lifecycle
Commonly referred to as the lifecycle of a virus, however, viruses are not considered living organisms.
Phases of the Replication Cycle
Absorption & Attachment
The virus must absorb to the host cell.
It uses a specific receptor on the host cell for attachment.
Example: Spike protein of COVID-19 recognizes a receptor on the cell surface.
Comparison to the:lock and key model:
The virus is the key fitting into the lock of the host cell receptor.
Penetration & Uncoating
Once attached, the virus penetrates the cell membrane.
The mechanism of uncoating can vary:
Direct entry entails membranes fusing, allowing the viral contents to enter.
Vesicular entry: the virus may enter in a vacuole that subsequently undergoes digestion, freeing the viral nucleic acid.
Synthesis
The viral DNA or RNA must be synthesized to produce proteins.
Types of nucleic acids:
Double-stranded RNA
Single-stranded RNA
Double-stranded DNA
Single-stranded DNA
The nucleic acid's type influences how the proteins are synthesized and how the genome is replicated.
Assembly Stage
Proteins that comprise the capsid are synthesized, often in the cytoplasm or nucleus.
The genome is replicated and organized into a capsid:
Capsid self-assembles.
The nucleic acid binds to the capsid, forming a nucleocapsid structure.
Spike proteins are inserted into the host cell membrane for future viral particles when they bud off.
Release of New Viruses
Types of Viruses & Release Mechanisms:
Non-enveloped viruses:
Released via cell lysis, rupturing the cell.
Enveloped viruses:
Released through exocytosis, budding off from the cell membrane.
Example: COVID-19 and HIV can exit this way.
Importance:
For flu viruses, viral proteins on the host membrane can be cleaved by an enzyme leading to release; Tamiflu inhibits this cleaving step.
Number of Released Virions:
The quantity of viruses released varies based on:
Virus type.
Health of the host cell.
Example Data:
Poxvirus can release 3,000 to 4,000 virions.
Polio virus can release up to 100,000 virions.
Consideration of cumulative impact of many infected cells.
Cytopathic Effects from Viral Infection
Definition of Cytopathic Effects:
Visible damage to host cells that can be observed microscopically.
Includes:
Changes in shape or size of cells
Presence of intracellular elements not typically found in healthy cells.
Examples include: Inclusion bodies (masses of viruses or damaged organelles) or syncytia (fusion of several infected cells into larger multi-nucleated cells).
Long-Term Presence of Viruses
Proviruses and Chronic Infections:
Some viruses integrate into the host genome or remain dormant:
Provirus: Viral DNA integrated into host DNA (Example: HIV).
Latent infections: Viruses that can reactivate later in life (e.g., Chickenpox -> Shingles).
Oncoviruses and Cancer
Oncoviruses:
About 20% of cancers are linked to oncoviruses.
Mechanisms of cancer transformation include:
Integration of viral oncogenes that promote uncontrolled cell growth.
Non-integrating viruses altering gene expression leading to malignancy.
Examples of oncogenic viruses:
Human Papillomavirus (HPV), Hepatitis B.
Bacteriophages: Viral Infections of Bacteria
Definition:
Bacteriophages are viruses that infect bacteria.
Two Replication Cycles:
Lytic Cycle:
Attachment, penetration, and immediate injection of DNA into bacteria, leading to cell lysis releasing new phages.
Lysogenic Cycle:
Infection leading to integration of viral DNA into bacterial DNA, replicated during bacterial division without immediate harm.
Induction of lytic cycle when conditions trigger viral activation.
Mechanisms of Viral Pathogenicity
Transduction:
Process where bacteriophages can transfer genetic material between bacterial cells, promoting virulence.
Examples of Bacteria and Associated Toxins:
Corynebacterium diphtheriae (diphtheria toxin).
Vibrio cholerae (cholera toxin).
Clostridium botulinum (botulinum toxin).
Treatment of Viral Infections
Challenges with Antibiotics:
Antibiotics target bacteria, not viruses.
Selective Toxicity Challenge:
Viruses depend on host cells for replication, making it difficult to target without impacting host cells directly.
Example treatment strategies for HIV focus on targeting unique features of its lifecycle (e.g., reverse transcriptase, integrase inhibitors).
Vaccines Against Viral Infections
Vaccine Development Variability:
The success of vaccine development varies due to virus behavior and replication mechanisms:
DNA viruses generally accumulate mutations slower than RNA viruses, making vaccines easier to develop for the former.
For example, polio vaccine development was highly successful compared to HIV.
Other Infectious Agents
Prions:
Infectious proteins causing neurodegenerative diseases (e.g., Creutzfeldt-Jakob, Mad Cow Disease).
They cause abnormal protein folding and aggregation leading to neurodegeneration.
Satellites and Viroids:
Satellite viruses: Require helper viruses for infection.
Viroids: Consist of short, circular RNA molecules, infecting plants with economic implications for agriculture.